The current projects represent the continuing development and expansion of our research program into the pathophysiology of vaso-occlusion and builds upon the historical strengths of our Center. With this proposal, we now move forward into two novel directions that explore new questions in sickle cell disease and strengthen collaborations between existing projects. Dr. Kohn will address an entirely new research objective for this Center in vitro and in vivo models of human erythropoiesis. Dr. Donald Kohn, one of the leading pediatric gene therapy investigators in this country, has developed a new method to expand stem cells from patients with sickle cell disease into mature erythrocytes or granulocytes in quantities sufficient to allow Dr. Meiselman to make biorheologic measurements of these cells prior to exposure to the in vivo environment and to allow Dr. Coates to study the intrinsic properties of sickle neutrophils. This approach will not only allow Dr. Meiselman to determine if b-globin related differences in sickle RBC rheologic properties are present in virginal sickle RBC, but also to measure the direct rheologic consequences of the genetic manipulations of the RBC proposed by Dr. Kohn. The novel model of human sickle erythropoiesis in the bnx-mouse will provide an in vivo environment for future exploration of hypothesis posed in other Projects. From the collaborations between Drs. Coates, Kalra and Meiselman, we have strong evidence that sickle erythrocytes specifically activate leukocytes which can then participate in endothelial damage. Dr. Coates Project will address the role that the reticuloendothelial systems, a major target in this disease, plays in disease manifestations. Two projects explore the intrinsic properties of the sickle RBC whole two other projects explore those characteristics of the vascular endothelium and reticuloendothelial system which contribute to vaso-occlusion. This closely knit ensemble of project directors have extensive histories of prior NIH support and bring expertise from wide-ranging backgrounds in basic research to bear on the problem of vaso-occlusion.
| Rabai, M; Detterich, J A; Wenby, R B et al. (2014) Effects of ethanol on red blood cell rheological behavior. Clin Hemorheol Microcirc 56:87-99 |
| Castellini, Michael; Elsner, Robert; Baskurt, Oguz K et al. (2006) Blood rheology of Weddell seals and bowhead whales. Biorheology 43:57-69 |
| Johnson, Cage S (2005) Arterial blood pressure and hyperviscosity in sickle cell disease. Hematol Oncol Clin North Am 19:827-37, vi |
| Senturk, Umit K; Yalcin, Ozlem; Gunduz, Filiz et al. (2005) Effect of antioxidant vitamin treatment on the time course of hematological and hemorheological alterations after an exhausting exercise episode in human subjects. J Appl Physiol 98:1272-9 |
| Johnson, Cage S (2005) The acute chest syndrome. Hematol Oncol Clin North Am 19:857-79, vi-vii |
| Baskurt, Oguz K; Yalcin, Ozlem; Meiselman, Herbert J (2004) Hemorheology and vascular control mechanisms. Clin Hemorheol Microcirc 30:169-78 |
| Armstrong, J K; Wenby, R B; Meiselman, H J et al. (2004) The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation. Biophys J 87:4259-70 |
| Baskurt, Oguz K; Yalcin, Ozlem; Ozdem, Sadi et al. (2004) Modulation of endothelial nitric oxide synthase expression by red blood cell aggregation. Am J Physiol Heart Circ Physiol 286:H222-9 |
| Batra, Sandeep; Perelman, Natalya; Luck, Lori R et al. (2003) Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival. Lab Invest 83:1477-87 |
| Chong-Martinez, B; Buchanan, T A; Wenby, R B et al. (2003) Decreased red blood cell aggregation subsequent to improved glycaemic control in Type 2 diabetes mellitus. Diabet Med 20:301-6 |
Showing the most recent 10 out of 66 publications
